AbstractObjectivesTonifying herbal medicines are used to nourish and balance the body’s qi, blood, yin, and yang, targeting deficiencies. They are the second most frequently used category by consumers visiting Korean medicine clinics, following prescriptions for back pain. This study aimed to analyze the adverse events associated with herbal medicine products classified as tonics through a national pharmacovigilance database.
MethodsWe investigated 11 types of tonifying herbal medicine products (466 product codes) in the Korea Adverse Event Reporting System (KAERS) database from 2012 to 2021. Extracted adverse event reports were analyzed based on information of reports, patient demographics, classification of adverse events, reported herbal medicine products, and causality assessment results.
ResultsA total of 31 individual case safety reports were identified, covering 33 adverse events. The annual number of reports has increased over the study period. Most reports were filed by physicians and pharmacists, with the majority of patients being adults or elderly. Gastrointestinal disorders were the most frequently reported adverse events, accounting for 48.5% of cases. Of the 33 adverse events, 93.9% were classified as non-serious, while 6.1% were classified as serious. The most frequently reported herbal medicine products were Bojungikgi-tang, Yukmijihwang-tang, and Palmijihwang-tang.
ConclusionsAlthough the study found that adverse events associated with tonifying herbal medicine products are generally not serious, it highlights the importance of systematic monitoring and reporting. The findings underscore the need for improved adverse event reporting systems within traditional Korean medicine to ensure patient safety and guide future research.
참고문헌1. Ministry of Health and Welfare. Pharmaceutical Affairs Act [Act No.20102];
3. WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance systems;(2004.
4. Cheon C. H., Park J. S., park S. J., Kweon K. T., Shin Y. C., & Ko S. G.(2011). Necessity of Adverse Event Reporting System through the Trend of Internet News about Safety of Herbal Medicine. Korean Journal Oriental Preventive Medical Society;15(2):131-143.
5. Oh J. W.(2023). Safety information reporting trends for pharmaceuticals in 2022 (KIDS-DSI_STAT_2023_Y). Korea Institute of Drug Safety and Risk Management.
7. Woo Y. J., Chung S. Y., & Park B. J.(2014). Current Status of Spontaneous Adverse Reactions Reporting System on Herbal Medicine in China, Japan, Korea and WHO. Journal of Internal Korean Medicine;35(2):111-118.
8. 12 College of Oriental medicine. Herbal Formula Science in Korean Medicine. Gun za publisher;(2023). p. P.455
9. Jung H. C., Park H. M., & Lee S. D.(2014). Nationwide Study on the Characteristics of Patients Visiting and Using Korean Medical Facilities by Sex. Journal of Korean Medicine;35(1):75-87.
https://doi.org/10.13048/jkm.14008
10. Lee W. Y., Park B. C., Kim H. S., Joung K.O., Yoon S. I., Kwon S. K., & Kim H. Y.(2007). A case of acute interstitial nephropathy and toxic hepatitis after short-term herbal medication. The Korean Journal of Medicine;73(1):103-106.
11. Lee E., Park B. W., Hea G. J., & Ko H.(2002). A Study on The Side Effects and Toxicity of Herbal Medicine. Korean Journal of Oriental Internal Medicine;23(2):222-227.
12. Lee M. H., Son B. W., Kim K. M., Jeon S. H., & Kim Y. K.(2018). A Study on Korean Traditional Medicine Side Effects Cases Described in Domestic Western Medical Journals in the Past 10 Years. Journal of Internal Korean Medicine;39(4):686-698.
http://dx.doi.org/10.22246/jikm.2018.39.4.686
13. Cho K. H., Seong W. S., Park S. U., Mon S. K., Kim Y. S., & Bae H. S.(2003). Clinical Assessment on the Safety of Chunghyul-dan (Qingwie-dan). Journal of Korean Medicine;24(3):45-50.
14. Yoon E. H., Jang M. G., Hwang J. H., Lee S. H., Jeong W. J., Lee J. D., & Kim E. J.(2010). Adverse Event Study on Ojeok-san Extract Powders RCT in Low Back Pain Patients. Journal of Korean Acupuncture & Moxibustion Society;27(4):195-202.
15. Lee K. B., Park Y. C., & Lee S. D.(2016). Characteristics of Toxicity Occurring in Outpatients at Korean Medical Clinics in Korean. Journal of Korean Medicine;37(1):135-150.
https://doi.org/10.13048/jkm.16013
16. Jung H. C., Park H. M., & Lee S. D.(2014). Nationwide Study on the Characteristics of Patients Visiting and Using Korean Medical Facilities by Sex. Journal of Korean Medicine;35(1):75-87.
https://doi.org/10.13048/jkm.14008
17. Woo Y. J.(2020). Estimation of Adverse Events Scale relating Herbal Medicine in Korea. Journal of Society of Preventive Korean Medicine;24(1):27-35. doi: 10.25153/spkom.2020.24.1.003
18. Kwon Y. J., Cho W. K., & Han C. H.(2012). Status of Herbal-drug-associated Adverse Drug Reactions Voluntarily Reported by EMR. Korean Journal of Oriental Internal Medicine;33(4):485-497.
19. Kim M. K., & Han C. H.(2015). Analysis of Herbal-drug-associated Adverse Drug Reactions Using Data from Spontaneous Reporting System in Electronic Medical Records. Journal of Korean Medicine;36(1):45-60.
https://doi.org/10.13048/jkm.15005
20. Lee S. H., Song B. W., Choi H. J., & Kim E. Y.(2017). The Analysis of Herbal Medicine-Associated Adverse Drug Reactions Spontaneously Reported in a Korean Medicine Hospital. Journal of Korean Society of Health-system Pharmacists;34(2):183-199.
21. Choi N. K., & Park B. j(2007). Adverse drug reaction surveillance system in Korea. Journal of Preventive Medicine and Public Health;40(4):278-284.
https://doi.org/10.3961/jpmph.2007.40.4.278
22. Choi H. J.(2018). The Internal Current Status and Prospect of Reports of Adverse Drug Reactions of Herbal Medicine: The Necessity of Report of Adverse Drug Reactions of Herbal Medicine and Henceforth Task. Pharmacoepidemiology and Risk Management;10(1):1-8.
|
|